Arvinas (ARVN) Profit After Tax (2017 - 2026)

Arvinas' (ARVN) quarterly Profit After Tax came in at -$57.6 million in Q1 2026, down 169.06% year-on-year from $83.4 million in Q1 2025, and up 14.79% quarter-over-quarter from -$67.6 million in Q4 2025.

Arvinas (ARVN) Profit After Tax (2017 - 2026) Analysis & Trends

Arvinas' Profit After Tax history runs 10 years deep, the most recent figure standing at -$57.6 million for Q1 2026.

  • On a quarterly basis, Profit After Tax fell 169.06% year-over-year to -$57.6 million in Q1 2026; TTM through Mar 2026 was -$221.1 million, a 488.03% decrease from a year earlier, with the FY2025 full-year figure at -$80.6 million, up 59.48% from the prior year.
  • Profit After Tax grew to -$57.6 million in Q1 2026 per ARVN's latest filing, from -$67.6 million in the prior quarter.
  • Across five years, Profit After Tax topped out at $83.4 million in Q1 2025 and bottomed at -$138.7 million in Q4 2023.
  • The 5-year median for Profit After Tax is -$62.7 million (2022), against an average of -$55.0 million.
  • Across the five-year window, Profit After Tax jumped 220.17% in 2025 and tumbled 169.06% in 2026, its largest moves.
  • Year by year, Profit After Tax stood at -$62.7 million in 2022, then plunged by 121.21% to -$138.7 million in 2023, then jumped by 67.48% to -$45.1 million in 2024, then slumped by 49.89% to -$67.6 million in 2025, then gained by 14.79% to -$57.6 million in 2026.
  • Per Business Quant, the three latest ARVN Profit After Tax figures stand at -$57.6 million (Q1 2026), -$67.6 million (Q4 2025), and -$34.7 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -36.84 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -14.46 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 227.36 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 1.03 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -65.60 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -26.94 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 498.00 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - -453.82 Mn
10 Arvinas 512.64 Mn -102.26 Mn - -57.60 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -57.60 Mn
Dec 31, 2025 -67.60 Mn
Sep 30, 2025 -34.70 Mn
Jun 30, 2025 -61.20 Mn
Mar 31, 2025 83.40 Mn
Dec 31, 2024 -45.10 Mn
Sep 30, 2024 -41.30 Mn
Jun 30, 2024 -34.60 Mn
Mar 31, 2024 -69.40 Mn
Dec 31, 2023 -138.70 Mn
Sep 30, 2023 -61.00 Mn
Jun 30, 2023 -66.60 Mn
Mar 31, 2023 -75.30 Mn
Dec 31, 2022 -62.70 Mn
Sep 30, 2022 -69.00 Mn
Jun 30, 2022 -70.00 Mn
Mar 31, 2022 -63.40 Mn
Dec 31, 2021 -51.80 Mn
Sep 30, 2021 -46.90 Mn
Jun 30, 2021 -50.50 Mn